Mini-chaperones

References

• Ebrahimi SM, Tebianian M. Role of mycobacterial heat shock protein 70 (mHSP70) as genetic vaccine adjuvants. World Applied Sciences Journal 2011; 14:1569 - 75
   Google Scholar
• Javid B, MacAry PA, Lehner PJ. Structure and function: heat shock proteins and adaptive immunity. J Immunol 2007; 179:2035 - 40; PMID: 17675458
   PubMed Web of Science ®Google Scholar
• Kim LS, Kim JH. Heat shock protein as molecular targets for breast cancer therapeutics. J Breast Cancer 2011; 14:167 - 74; http://dx.doi.org/10.4048/jbc.2011.14.3.167; PMID: 22031796
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Gong J. Molecular chaperones in mammary cancer growth and breast tumor therapy. J Cell Biochem 2012; 113:1096 - 103; http://dx.doi.org/10.1002/jcb.23461; PMID: 22105880
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Stevenson MA, Calderwood SK. Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come. Expert Rev Vaccines 2011; 10:1553 - 68; http://dx.doi.org/10.1586/erv.11.124; PMID: 22043955
   PubMed Web of Science ®Google Scholar
• Li Z. In vitro reconstitution of heat shock protein-peptide complexes for generating peptide-specific vaccines against cancers and infectious diseases. Methods 2004; 32:25 - 8; http://dx.doi.org/10.1016/S1046-2023(03)00183-X; PMID: 14624873
   PubMed Web of Science ®Google Scholar
• Blachere NE, Li Z, Chandawarkar RY, Suto R, Jaikaria NS, Basu S, et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 1997; 186:1315 - 22; http://dx.doi.org/10.1084/jem.186.8.1315; PMID: 9334371
   PubMed Web of Science ®Google Scholar
• Wang HH, Mao CY, Teng LS, Cao J. Recent advances in heat shock protein-based cancer vaccines. Hepatobiliary Pancreat Dis Int 2006; 5:22 - 7; PMID: 16481277
   PubMedGoogle Scholar
• Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20:395 - 425; http://dx.doi.org/10.1146/annurev.immunol.20.100301.064801; PMID: 11861608
   PubMed Web of Science ®Google Scholar
• Takakura Y, Takemoto S, Nishikawa M. Hsp-based tumor vaccines: state-of-the-art and future directions. Curr Opin Mol Ther 2007; 9:385 - 91; PMID: 17694451
   PubMed Web of Science ®Google Scholar
• Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010; 2:238 - 47; http://dx.doi.org/10.1159/000296508; PMID: 20375559
   PubMed Web of Science ®Google Scholar
• Biswas C, Sriram U, Ciric B, Ostrovsky O, Gallucci S, Argon Y. The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells. Int Immunol 2006; 18:1147 - 57; http://dx.doi.org/10.1093/intimm/dxl049; PMID: 16772370
   PubMed Web of Science ®Google Scholar
• Bolhassani A, Mohit E, Rafati S. Different spectra of therapeutic vaccine development against HPV infections. Hum Vaccin 2009; 5:671 - 89; http://dx.doi.org/10.4161/hv.5.10.9370; PMID: 19684468
   PubMed Web of Science ®Google Scholar
• Udono H, Yamano T, Kawabata Y, Ueda M, Yui K. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol 2001; 13:1233 - 42; http://dx.doi.org/10.1093/intimm/13.10.1233; PMID: 11581168
   PubMed Web of Science ®Google Scholar
• Ramirez SR, Singh-Jasuja H, Warger T, Braedel-Ruoff S, Hilf N, Wiemann K, et al. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response. Cell Stress Chaperones 2005; 10:221 - 9; http://dx.doi.org/10.1379/CSC-117R.1; PMID: 16184767
   PubMed Web of Science ®Google Scholar
• Callahan MK, Garg M, Srivastava PK. Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation. Proc Natl Acad Sci USA 2008; 105:1662 - 7; http://dx.doi.org/10.1073/pnas.0711365105; PMID: 18216248
   PubMed Web of Science ®Google Scholar
• Bolhassani A, Rafati S. Heat-shock proteins as powerful weapons in vaccine development. Expert Rev Vaccines 2008; 7:1185 - 99; http://dx.doi.org/10.1586/14760584.7.8.1185; PMID: 18844593
   PubMed Web of Science ®Google Scholar
• Binder RJ, Vatner R, Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 2004; 64:442 - 51; http://dx.doi.org/10.1111/j.1399-0039.2004.00299.x; PMID: 15361121
   PubMed Web of Science ®Google Scholar
• Figueiredo C, Wittmann M, Wang D, Dressel R, Seltsam A, Blasczyk R, et al. Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells. Blood 2009; 113:3008 - 16; http://dx.doi.org/10.1182/blood-2008-06-162727; PMID: 19018093
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14:303 - 13; http://dx.doi.org/10.1016/S1074-7613(01)00111-X; PMID: 11290339
   PubMed Web of Science ®Google Scholar
• Asea A. Heat shock proteins and toll-like receptors. Handb Exp Pharmacol 2008; 183:111 - 27; http://dx.doi.org/10.1007/978-3-540-72167-3_6; PMID: 18071657
   PubMedGoogle Scholar
• Mandal K, Foteinos G, Jahangiri M, Xu Q. Role of antiheat shock protein 60 autoantibodies in atherosclerosis. Lupus 2005; 14:742 - 6; http://dx.doi.org/10.1191/0961203305lu2212oa; PMID: 16218479
   PubMed Web of Science ®Google Scholar
• Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 2004; 22:361 - 403; http://dx.doi.org/10.1146/annurev.immunol.22.012703.104644; PMID: 15032582
   PubMed Web of Science ®Google Scholar
• van Halteren AG, Roep BO, Gregori S, Cooke A, van Eden W, Kraal G, et al. Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice. J Autoimmun 2002; 18:139 - 47; http://dx.doi.org/10.1006/jaut.2001.0578; PMID: 11908946
   PubMed Web of Science ®Google Scholar
• Abulafia-Lapid R, Gillis D, Yosef O, Atlan H, Cohen IR. T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J Autoimmun 2003; 20:313 - 21; http://dx.doi.org/10.1016/S0896-8411(03)00038-6; PMID: 12791317
   PubMed Web of Science ®Google Scholar
• Salvetti M, Ristori G, Buttinelli C, Fiori P, Falcone M, Britton W, et al. The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J Neuroimmunol 1996; 65:143 - 53; http://dx.doi.org/10.1016/0165-5728(96)00013-6; PMID: 8964896
   PubMed Web of Science ®Google Scholar
• Todryk SM, Gough MJ, Pockley AG. Facets of heat shock protein 70 show immunotherapeutic potential. Immunology 2003; 110:1 - 9; http://dx.doi.org/10.1046/j.1365-2567.2003.01725.x; PMID: 12941135
   PubMed Web of Science ®Google Scholar
• Hunt C, Morimoto RI. Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci USA 1985; 82:6455 - 9; http://dx.doi.org/10.1073/pnas.82.19.6455; PMID: 3931075
   PubMed Web of Science ®Google Scholar
• Yan Y, Cao Z, Yang M, Li H, Wei H, Fu Y, et al. A CpG oligodeoxynucleotide potentiates the anti-tumor effect of HSP65-Her2 fusion protein against Her2 positive B16 melanoma in mice. Int Immunopharmacol 2012; 12:402 - 7; http://dx.doi.org/10.1016/j.intimp.2011.12.013; PMID: 22222115
   PubMed Web of Science ®Google Scholar
• Wang QH, Buckle AM, Fersht AR. From mini-chaperone to GroEL. J Mol Biol 2000; 304:837 - 81
   Web of Science ®Google Scholar
• Chatellier J, Hill F, Lund PA, Fersht AR. In vivo activities of GroEL minichaperones. Proc Natl Acad Sci USA 1998; 95:9861 - 6; http://dx.doi.org/10.1073/pnas.95.17.9861; PMID: 9707566
   PubMed Web of Science ®Google Scholar
• Bolhassani A, Rafati S. DNA immunization as an efficient strategy for vaccination. Avicenna Journal of Medical Biotechnology 2009; 1:71 - 88
   PubMedGoogle Scholar
• Li X, Yang X, Li L, Liu H, Liu J. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine 2006; 24:3321 - 31; http://dx.doi.org/10.1016/j.vaccine.2006.01.012; PMID: 16472546
   PubMed Web of Science ®Google Scholar
• Qazi KR, Wikman M, Vasconcelos NM, Berzins K, Ståhl S, Fernández C. Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine 2005; 23:1114 - 25; http://dx.doi.org/10.1016/j.vaccine.2004.08.033; PMID: 15629354
   PubMed Web of Science ®Google Scholar
• Chunxia S, Duan X, Wang X, Wang C, Cao R, Zhou B, et al. Heterologous expression of FMDV immunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice. Veterinary Microbiol 2006; 124:256 - 263
   Web of Science ®Google Scholar
• Ge FF, Qiu YF, Gao XF, Yang YW, Chen PY. Fusion expression of major antigenic segment of JEV E protein-hsp70 and the identification of domain acting as adjuvant in hsp70. Vet Immunol Immunopathol 2006; 113:288 - 96; http://dx.doi.org/10.1016/j.vetimm.2006.05.012; PMID: 16859755
   PubMed Web of Science ®Google Scholar
• Uto T, Tsujimura K, Uchijima M, Seto S, Nagata T, Suda T, et al. A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70. FEMS Immunol Med Microbiol 2011; 61:189 - 96; http://dx.doi.org/10.1111/j.1574-695X.2010.00762.x; PMID: 21204994
   PubMed Web of Science ®Google Scholar
• Pakravan N, Soudi S, Hassan ZM. N-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine. Cell Stress Chaperones 2010; 15:631 - 8; http://dx.doi.org/10.1007/s12192-010-0175-0; PMID: 20224916
   PubMed Web of Science ®Google Scholar
• Lehner T, Wang Y, Whittall T, McGowan E, Kelly CG, Singh M. Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity. Biochem Soc Trans 2004; 32:629 - 32; http://dx.doi.org/10.1042/BST0320629; PMID: 15270693
   PubMed Web of Science ®Google Scholar
• Facciponte JG, Wang XY, MacDonald IJ, Park JE, Arnouk H, Grimm MJ, et al. Heat shock proteins HSP70 and GP96: structural insights. Cancer Immunol Immunother 2006; 55:339 - 46; http://dx.doi.org/10.1007/s00262-005-0020-y; PMID: 16032399
   PubMed Web of Science ®Google Scholar
• Bolhassani A, Zahedifard F, Taghikhani M, Rafati S. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies. Vaccine 2008; 26:3362 - 70; http://dx.doi.org/10.1016/j.vaccine.2008.03.082; PMID: 18471945
   PubMed Web of Science ®Google Scholar
• Pakravan N, Langroudi L, Hajimoradi M, Hassan ZM. Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model. Cell Stress Chaperones 2010; 15:977 - 84; http://dx.doi.org/10.1007/s12192-010-0208-8; PMID: 20544406
   PubMed Web of Science ®Google Scholar
• Manjili MH, Wang XY, Chen X, Martin T, Repasky EA, Henderson R, et al. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J Immunol 2003; 171:4054 - 61; PMID: 14530326
   PubMed Web of Science ®Google Scholar
• He YF, Wang XH, Zhang GM, Chen HT, Zhang H, Feng ZH. Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol Immunother 2005; 54:891 - 7; http://dx.doi.org/10.1007/s00262-004-0654-1; PMID: 15776283
   PubMed Web of Science ®Google Scholar
• Kmieciak M, Knutson KL, Dumur CI, Manjili MH. HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses. Eur J Immunol 2007; 37:675 - 85; http://dx.doi.org/10.1002/eji.200636639; PMID: 17304628
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
   PubMed Web of Science ®Google Scholar
• Pakravan N, Hashemi SM, Hassan ZM. Adjuvant activity of GP96 C-terminal domain towards Her2/neu DNA vaccine is fusion direction-dependent. Cell Stress Chaperones 2011; 16:41 - 8; http://dx.doi.org/10.1007/s12192-010-0219-5; PMID: 20730610
   PubMed Web of Science ®Google Scholar
• Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009; 458:438 - 44; http://dx.doi.org/10.1038/nature07960; PMID: 19325623
   PubMed Web of Science ®Google Scholar
• Pakravan N, Hassan ZM. Comparison of adjuvant activity of N- and C-terminal domain of gp96 in a Her2-positive breast cancer model. Cell Stress Chaperones 2011; 16:449 - 57; http://dx.doi.org/10.1007/s12192-011-0258-6; PMID: 21359667
   PubMed Web of Science ®Google Scholar
• Li H, Zhou M, Han J, Zhu X, Dong T, Gao GF, et al. Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments. J Immunol 2005; 174:195 - 204; PMID: 15611241
   PubMed Web of Science ®Google Scholar
• Rapp UK, Kaufmann SH. DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen. Int Immunol 2004; 16:597 - 605; http://dx.doi.org/10.1093/intimm/dxh064; PMID: 15039390
   PubMed Web of Science ®Google Scholar
• Pakravan N, Soleimanjahi H, Hassan ZM. GP96 C-terminal improves Her2/neu DNA vaccine. J Gene Med 2010; 12:345 - 53; http://dx.doi.org/10.1002/jgm.1445; PMID: 20232284
   PubMed Web of Science ®Google Scholar
• Mohit E, Bolhassani A, Zahedifard F, Seyed N, Eslamifar A, Taghikhani M, et al. Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections. Mol Immunol 2013; 53:149 - 60; http://dx.doi.org/10.1016/j.molimm.2012.07.011; PMID: 22926003
   PubMed Web of Science ®Google Scholar
• Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, et al. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2010; 2:63ra94; http://dx.doi.org/10.1126/scitranslmed.3001375; PMID: 21178137
   PubMed Web of Science ®Google Scholar
• Pike SE, Yao L, Jones KD, Cherney B, Appella E, Sakaguchi K, et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 1998; 188:2349 - 56; http://dx.doi.org/10.1084/jem.188.12.2349; PMID: 9858521
   PubMed Web of Science ®Google Scholar
• Liu B, Ye D, Song X, Zhao X, Yi L, Song J, et al. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Vaccine 2008; 26:1387 - 96; http://dx.doi.org/10.1016/j.vaccine.2007.12.034; PMID: 18272260
   PubMed Web of Science ®Google Scholar
• Bolhassani A, Zahedifard F, Taslimi Y, Taghikhani M, Nahavandian B, Rafati S. Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients. Indian J Med Res 2009; 130:533 - 41; PMID: 20090101
   PubMed Web of Science ®Google Scholar
• Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model. Scand J Immunol 2012; 75:27 - 37; http://dx.doi.org/10.1111/j.1365-3083.2011.02620.x; PMID: 21916914
   PubMed Web of Science ®Google Scholar
• Abdian N, Gholami E, Zahedifard F, Safaee N, Rafati S. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis. Exp Parasitol 2011; 127:627 - 36; http://dx.doi.org/10.1016/j.exppara.2010.12.007; PMID: 21187087
   PubMed Web of Science ®Google Scholar
• Tebianian M, Hoseini AZ, Ebrahimi SM, Memarnejadian A, Mokarram AR, Mahdavi M, et al. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70. Biologicals 2011; 39:143 - 8; http://dx.doi.org/10.1016/j.biologicals.2011.02.002; PMID: 21388826
   PubMed Web of Science ®Google Scholar
• Suzue K, Young RA. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 1996 a; 156:873 - 9; PMID: 8543845
   PubMed Web of Science ®Google Scholar
• Suzue K, Young RA. Heat shock proteins as immunological carriers and vaccines. EXS 1996 b; 77:451 - 65; PMID: 8856990
   PubMedGoogle Scholar
• Ebrahimi SM, Tebianian M. Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70(359-610) in prokaryotic system as a fusion protein. Mol Biol Rep 2010; 37:2877 - 83; http://dx.doi.org/10.1007/s11033-009-9846-2; PMID: 19813102
   PubMed Web of Science ®Google Scholar
• Ebrahimi SM, Tebianian M, Mirjalili A, Paykari H, Varshovi HR, Toghyani H, et al. Fusion and sequence analysis of the influenza A (H9N2) virus M2e and C-terminal fragment of Mycobacterium tuberculosis HSP70 (H37Rv). Archives of Razi Institute 2009; 64:71 - 6
   Google Scholar
• Li YL, Liu J, Liu JN, Zhang J. Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice. Vaccine 2011; 29:5959 - 62; http://dx.doi.org/10.1016/j.vaccine.2011.06.046; PMID: 21722685
   PubMed Web of Science ®Google Scholar
• Barrios C, Lussow AR, Van Embden J, Van der Zee R, Rappuoli R, Costantino P, et al. Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming. Eur J Immunol 1992; 22:1365 - 72; http://dx.doi.org/10.1002/eji.1830220606; PMID: 1601031
   PubMed Web of Science ®Google Scholar
• Marañón C, Thomas MC, Planelles L, López MC. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes. Mol Immunol 2001; 38:279 - 87; http://dx.doi.org/10.1016/S0161-5890(01)00059-1; PMID: 11566321
   PubMed Web of Science ®Google Scholar
• Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, et al. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J Immunol 2002; 169:2422 - 9; PMID: 12193710
   PubMed Web of Science ®Google Scholar
• Lehner T, Wang Y, Whittall T, McGowan E, Kelly CG, Singh M. Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity. Biochem Soc Trans 2004; 32:629 - 32; http://dx.doi.org/10.1042/BST0320629; PMID: 15270693
   PubMed Web of Science ®Google Scholar
• Rico AI, Angel SO, Alonso C, Requena JM. Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol 1999; 36:1131 - 9; http://dx.doi.org/10.1016/S0161-5890(99)00136-4; PMID: 10698315
   PubMed Web of Science ®Google Scholar
• Rafati S, Gholami E, Hassani N, Ghaemimanesh F, Taslimi Y, Taheri T, et al. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients. Vaccine 2007; 25:4159 - 69; http://dx.doi.org/10.1016/j.vaccine.2007.03.006; PMID: 17395340
   PubMed Web of Science ®Google Scholar
• Li HT, Yan JB, Li J, Zhou MH, Zhu XD, Zhang YX, et al. Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice. World J Gastroenterol 2005; 11:2858 - 63; PMID: 15902719
   PubMed Web of Science ®Google Scholar
• Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Löwik MJ, Berends-van der Meer DM, et al. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin Cancer Res 2008; 14:178 - 87; http://dx.doi.org/10.1158/1078-0432.CCR-07-1880; PMID: 18172269
   PubMed Web of Science ®Google Scholar
• Udono H, Yamano T, Kawabata Y, Ueda M, Yui K. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol 2001; 13:1233 - 42; http://dx.doi.org/10.1093/intimm/13.10.1233; PMID: 11581168
   PubMed Web of Science ®Google Scholar
• Li H, Zhou M, Han J, Zhu X, Dong T, Gao GF, et al. Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments. J Immunol 2005; 174:195 - 204; PMID: 15611241
   PubMed Web of Science ®Google Scholar